1 January 2025 - The January 2025 issue of the New Zealand Pharmaceutical Schedule is now available and in effect.

There are several new/revised listings of note this month:

• Osimertinib mesylate (Tagrisso) - new indication
• Trastuzumab deruxtecan (Enhertu) - new medicine
• Palivizumab (Synagis) - new indication
• Budesonide with eformoterol fumarate dihydrate and glycopyrronium bromide (Brezetri Aerosphere)

Read New Zealand Pharmaceutical Schedule update